STOCK TITAN

[Form 4] First Busey Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Dynex Capital (DX) filed an 8-K announcing Amendment No. 7 to its 2018 at-the-market (ATM) equity distribution agreement with ten sales agents, including J.P. Morgan, UBS and Wells Fargo. The amendment raises the share capacity by 61,939,730 shares, lifting the total amount that can be issued under the program to 161,292,973 common shares. After prior issuances, approximately 75 million shares remain available for sale.

The new shares are registered on the Company’s Form S-3 (File No. 333-289004). Sales will be made from time to time through the agents as "at-the-market offerings" under Rule 415(a)(4); the agents will receive customary fees and commissions. Dynex also filed (i) the full text of Amendment No. 7 (Ex. 10.1) and (ii) a legal opinion from Mayer Brown LLP regarding the shares’ validity (Ex. 5.1/23.1).

Implications for investors:

  • Liquidity boost: Expanding the ATM program provides management with flexibility to raise cash quickly without a traditional follow-on offering.
  • Dilution risk: Issuing up to 75 million additional shares would materially dilute existing shareholders if fully placed.
  • No operating metrics: The filing does not include earnings, leverage or book-value updates; the amendment solely concerns capital-raising capacity.

Dynex Capital (DX) ha presentato un 8-K annunciando la Modifica n. 7 al suo accordo di distribuzione azionaria sul mercato (ATM) del 2018 con dieci agenti di vendita, tra cui J.P. Morgan, UBS e Wells Fargo. La modifica aumenta la capacità azionaria di 61.939.730 azioni, portando il totale delle azioni che possono essere emesse nell'ambito del programma a 161.292.973 azioni ordinarie. Dopo le emissioni precedenti, circa 75 milioni di azioni rimangono disponibili per la vendita.

Le nuove azioni sono registrate nel modulo S-3 della Società (File No. 333-289004). Le vendite saranno effettuate di volta in volta tramite gli agenti come "offerte sul mercato" ai sensi della Regola 415(a)(4); gli agenti riceveranno commissioni e compensi consueti. Dynex ha inoltre depositato (i) il testo completo della Modifica n. 7 (Ex. 10.1) e (ii) un parere legale di Mayer Brown LLP riguardante la validità delle azioni (Ex. 5.1/23.1).

Implicazioni per gli investitori:

  • Aumento della liquidità: L'espansione del programma ATM offre alla direzione la flessibilità di raccogliere rapidamente liquidità senza un'offerta tradizionale di follow-on.
  • Rischio di diluizione: L'emissione di fino a 75 milioni di azioni aggiuntive diluirebbe significativamente gli azionisti esistenti se completamente collocate.
  • Nessun aggiornamento operativo: Il deposito non include aggiornamenti su utili, leva finanziaria o valore contabile; la modifica riguarda esclusivamente la capacità di raccolta di capitale.

Dynex Capital (DX) presentó un 8-K anunciando la Enmienda No. 7 a su acuerdo de distribución de acciones en el mercado (ATM) de 2018 con diez agentes de ventas, incluyendo J.P. Morgan, UBS y Wells Fargo. La enmienda incrementa la capacidad de acciones en 61,939,730 acciones, elevando el total que puede emitirse bajo el programa a 161,292,973 acciones comunes. Tras emisiones previas, aproximadamente 75 millones de acciones permanecen disponibles para la venta.

Las nuevas acciones están registradas en el Formulario S-3 de la Compañía (Archivo No. 333-289004). Las ventas se realizarán ocasionalmente a través de los agentes como "ofertas en el mercado" bajo la Regla 415(a)(4); los agentes recibirán las comisiones y honorarios habituales. Dynex también presentó (i) el texto completo de la Enmienda No. 7 (Ex. 10.1) y (ii) una opinión legal de Mayer Brown LLP sobre la validez de las acciones (Ex. 5.1/23.1).

Implicaciones para los inversores:

  • Impulso a la liquidez: Ampliar el programa ATM brinda a la dirección flexibilidad para recaudar efectivo rápidamente sin una oferta secundaria tradicional.
  • Riesgo de dilución: Emitir hasta 75 millones de acciones adicionales diluiría materialmente a los accionistas existentes si se colocan completamente.
  • Sin métricas operativas: La presentación no incluye actualizaciones de ganancias, apalancamiento o valor en libros; la enmienda solo se refiere a la capacidad de recaudación de capital.

Dynex Capital (DX)8-K를 제출하여 J.P. Morgan, UBS, Wells Fargo를 포함한 10명의 판매 대리인과 체결한 2018년 시장 내 주식 배포 계약(ATM)의 7차 수정안을 발표했습니다. 이 수정안은 주식 수용량을 61,939,730주 증가시켜 프로그램 하에서 발행 가능한 총 주식을 161,292,973주로 확대했습니다. 이전 발행 후 약 7,500만 주가 여전히 판매 가능합니다.

신규 주식은 회사의 Form S-3 (파일 번호 333-289004)에 등록되어 있습니다. 판매는 규칙 415(a)(4)에 따라 대리인을 통해 수시로 '시장 내 제공' 방식으로 이루어지며, 대리인은 관례적인 수수료와 커미션을 받게 됩니다. Dynex는 또한 (i) 7차 수정안 전문(Ex. 10.1)과 (ii) 주식의 유효성에 관한 Mayer Brown LLP의 법률 의견서(Ex. 5.1/23.1)를 제출했습니다.

투자자에 대한 영향:

  • 유동성 강화: ATM 프로그램 확장은 경영진이 전통적인 후속 공모 없이 신속하게 현금을 조달할 수 있는 유연성을 제공합니다.
  • 희석 위험: 최대 7,500만 주 추가 발행 시 기존 주주들의 지분이 상당히 희석될 수 있습니다.
  • 운영 지표 없음: 제출 서류에는 수익, 레버리지 또는 장부가치 업데이트가 포함되어 있지 않으며, 수정안은 자본 조달 능력에만 관련됩니다.

Dynex Capital (DX) a déposé un 8-K annonçant la Modification n°7 de son accord de distribution d'actions sur le marché (ATM) de 2018 avec dix agents de vente, dont J.P. Morgan, UBS et Wells Fargo. La modification augmente la capacité d'actions de 61 939 730 actions, portant le total pouvant être émis dans le cadre du programme à 161 292 973 actions ordinaires. Après les émissions précédentes, environ 75 millions d'actions restent disponibles à la vente.

Les nouvelles actions sont enregistrées dans le formulaire S-3 de la société (dossier n° 333-289004). Les ventes seront réalisées de temps à autre par les agents en tant qu'« offres sur le marché » selon la règle 415(a)(4) ; les agents percevront les commissions et frais habituels. Dynex a également déposé (i) le texte complet de la Modification n°7 (Ex. 10.1) et (ii) un avis juridique de Mayer Brown LLP concernant la validité des actions (Ex. 5.1/23.1).

Implications pour les investisseurs :

  • Renforcement de la liquidité : L'extension du programme ATM offre à la direction la flexibilité de lever rapidement des fonds sans émission secondaire traditionnelle.
  • Risque de dilution : L'émission pouvant aller jusqu'à 75 millions d'actions supplémentaires diluerait significativement les actionnaires existants si elle était entièrement placée.
  • Aucune donnée opérationnelle : Le dépôt ne comprend pas de mises à jour sur les bénéfices, l'endettement ou la valeur comptable ; la modification concerne uniquement la capacité de levée de capitaux.

Dynex Capital (DX) hat eine 8-K-Meldung eingereicht, in der die Änderung Nr. 7 ihres 2018er At-the-Market (ATM) Aktienvertriebsabkommens mit zehn Verkaufsagenten, darunter J.P. Morgan, UBS und Wells Fargo, bekanntgegeben wird. Die Änderung erhöht die Aktienkapazität um 61.939.730 Aktien und hebt die Gesamtanzahl der unter dem Programm ausgebbaren Aktien auf 161.292.973 Stammaktien an. Nach vorherigen Emissionen sind etwa 75 Millionen Aktien noch verfügbar zum Verkauf.

Die neuen Aktien sind im Formular S-3 des Unternehmens (Datei Nr. 333-289004) registriert. Die Verkäufe erfolgen von Zeit zu Zeit über die Agenten als "At-the-Market-Angebote" gemäß Regel 415(a)(4); die Agenten erhalten übliche Gebühren und Provisionen. Dynex hat zudem (i) den vollständigen Text der Änderung Nr. 7 (Ex. 10.1) und (ii) ein Rechtsgutachten von Mayer Brown LLP zur Gültigkeit der Aktien (Ex. 5.1/23.1) eingereicht.

Auswirkungen für Investoren:

  • Liquiditätssteigerung: Die Erweiterung des ATM-Programms gibt dem Management die Flexibilität, schnell Kapital zu beschaffen, ohne ein traditionelles Folgeangebot.
  • Verwässerungsrisiko: Die Ausgabe von bis zu 75 Millionen zusätzlichen Aktien würde die bestehenden Aktionäre erheblich verwässern, falls vollständig platziert.
  • Keine operativen Kennzahlen: Die Einreichung enthält keine Updates zu Gewinn, Verschuldung oder Buchwert; die Änderung betrifft ausschließlich die Kapitalbeschaffungskapazität.
Positive
  • Enhanced funding flexibility: Raising ATM limit allows Dynex to access equity opportunistically without a full public offering.
  • Large unissued capacity: 75 M shares remain, potentially strengthening balance-sheet liquidity if executed judiciously.
Negative
  • Dilution overhang: Issuance of up to 75 M additional shares could materially dilute existing shareholders.
  • Uncertain capital need: Filing does not explain why such a sizable increase is required, leaving questions about future leverage or asset purchases.

Insights

TL;DR: Dynex increases ATM size to 161 M shares, giving liquidity flexibility but creating potential dilution overhang; impact depends on issuance pace.

The 61.9 M-share expansion nearly doubles the program versus the original 99.4 M limit, signalling management’s willingness to tap equity markets amid volatile mortgage-REIT funding conditions. With ~75 M shares still unissued, the company could raise roughly $750-$800 M at the recent $10/share price—equal to ~55-60% of current market cap. While added capital may support portfolio growth or debt reduction, continual ATM issuance typically weighs on per-share book value and dividend capacity. Because the amendment does not mandate issuance timing, short-term impact is neutral; long-term share count creep could pressure valuation multiples.
Impact rating: 0 (neutral—benefits liquidity but dilutive risk is contingent).

Dynex Capital (DX) ha presentato un 8-K annunciando la Modifica n. 7 al suo accordo di distribuzione azionaria sul mercato (ATM) del 2018 con dieci agenti di vendita, tra cui J.P. Morgan, UBS e Wells Fargo. La modifica aumenta la capacità azionaria di 61.939.730 azioni, portando il totale delle azioni che possono essere emesse nell'ambito del programma a 161.292.973 azioni ordinarie. Dopo le emissioni precedenti, circa 75 milioni di azioni rimangono disponibili per la vendita.

Le nuove azioni sono registrate nel modulo S-3 della Società (File No. 333-289004). Le vendite saranno effettuate di volta in volta tramite gli agenti come "offerte sul mercato" ai sensi della Regola 415(a)(4); gli agenti riceveranno commissioni e compensi consueti. Dynex ha inoltre depositato (i) il testo completo della Modifica n. 7 (Ex. 10.1) e (ii) un parere legale di Mayer Brown LLP riguardante la validità delle azioni (Ex. 5.1/23.1).

Implicazioni per gli investitori:

  • Aumento della liquidità: L'espansione del programma ATM offre alla direzione la flessibilità di raccogliere rapidamente liquidità senza un'offerta tradizionale di follow-on.
  • Rischio di diluizione: L'emissione di fino a 75 milioni di azioni aggiuntive diluirebbe significativamente gli azionisti esistenti se completamente collocate.
  • Nessun aggiornamento operativo: Il deposito non include aggiornamenti su utili, leva finanziaria o valore contabile; la modifica riguarda esclusivamente la capacità di raccolta di capitale.

Dynex Capital (DX) presentó un 8-K anunciando la Enmienda No. 7 a su acuerdo de distribución de acciones en el mercado (ATM) de 2018 con diez agentes de ventas, incluyendo J.P. Morgan, UBS y Wells Fargo. La enmienda incrementa la capacidad de acciones en 61,939,730 acciones, elevando el total que puede emitirse bajo el programa a 161,292,973 acciones comunes. Tras emisiones previas, aproximadamente 75 millones de acciones permanecen disponibles para la venta.

Las nuevas acciones están registradas en el Formulario S-3 de la Compañía (Archivo No. 333-289004). Las ventas se realizarán ocasionalmente a través de los agentes como "ofertas en el mercado" bajo la Regla 415(a)(4); los agentes recibirán las comisiones y honorarios habituales. Dynex también presentó (i) el texto completo de la Enmienda No. 7 (Ex. 10.1) y (ii) una opinión legal de Mayer Brown LLP sobre la validez de las acciones (Ex. 5.1/23.1).

Implicaciones para los inversores:

  • Impulso a la liquidez: Ampliar el programa ATM brinda a la dirección flexibilidad para recaudar efectivo rápidamente sin una oferta secundaria tradicional.
  • Riesgo de dilución: Emitir hasta 75 millones de acciones adicionales diluiría materialmente a los accionistas existentes si se colocan completamente.
  • Sin métricas operativas: La presentación no incluye actualizaciones de ganancias, apalancamiento o valor en libros; la enmienda solo se refiere a la capacidad de recaudación de capital.

Dynex Capital (DX)8-K를 제출하여 J.P. Morgan, UBS, Wells Fargo를 포함한 10명의 판매 대리인과 체결한 2018년 시장 내 주식 배포 계약(ATM)의 7차 수정안을 발표했습니다. 이 수정안은 주식 수용량을 61,939,730주 증가시켜 프로그램 하에서 발행 가능한 총 주식을 161,292,973주로 확대했습니다. 이전 발행 후 약 7,500만 주가 여전히 판매 가능합니다.

신규 주식은 회사의 Form S-3 (파일 번호 333-289004)에 등록되어 있습니다. 판매는 규칙 415(a)(4)에 따라 대리인을 통해 수시로 '시장 내 제공' 방식으로 이루어지며, 대리인은 관례적인 수수료와 커미션을 받게 됩니다. Dynex는 또한 (i) 7차 수정안 전문(Ex. 10.1)과 (ii) 주식의 유효성에 관한 Mayer Brown LLP의 법률 의견서(Ex. 5.1/23.1)를 제출했습니다.

투자자에 대한 영향:

  • 유동성 강화: ATM 프로그램 확장은 경영진이 전통적인 후속 공모 없이 신속하게 현금을 조달할 수 있는 유연성을 제공합니다.
  • 희석 위험: 최대 7,500만 주 추가 발행 시 기존 주주들의 지분이 상당히 희석될 수 있습니다.
  • 운영 지표 없음: 제출 서류에는 수익, 레버리지 또는 장부가치 업데이트가 포함되어 있지 않으며, 수정안은 자본 조달 능력에만 관련됩니다.

Dynex Capital (DX) a déposé un 8-K annonçant la Modification n°7 de son accord de distribution d'actions sur le marché (ATM) de 2018 avec dix agents de vente, dont J.P. Morgan, UBS et Wells Fargo. La modification augmente la capacité d'actions de 61 939 730 actions, portant le total pouvant être émis dans le cadre du programme à 161 292 973 actions ordinaires. Après les émissions précédentes, environ 75 millions d'actions restent disponibles à la vente.

Les nouvelles actions sont enregistrées dans le formulaire S-3 de la société (dossier n° 333-289004). Les ventes seront réalisées de temps à autre par les agents en tant qu'« offres sur le marché » selon la règle 415(a)(4) ; les agents percevront les commissions et frais habituels. Dynex a également déposé (i) le texte complet de la Modification n°7 (Ex. 10.1) et (ii) un avis juridique de Mayer Brown LLP concernant la validité des actions (Ex. 5.1/23.1).

Implications pour les investisseurs :

  • Renforcement de la liquidité : L'extension du programme ATM offre à la direction la flexibilité de lever rapidement des fonds sans émission secondaire traditionnelle.
  • Risque de dilution : L'émission pouvant aller jusqu'à 75 millions d'actions supplémentaires diluerait significativement les actionnaires existants si elle était entièrement placée.
  • Aucune donnée opérationnelle : Le dépôt ne comprend pas de mises à jour sur les bénéfices, l'endettement ou la valeur comptable ; la modification concerne uniquement la capacité de levée de capitaux.

Dynex Capital (DX) hat eine 8-K-Meldung eingereicht, in der die Änderung Nr. 7 ihres 2018er At-the-Market (ATM) Aktienvertriebsabkommens mit zehn Verkaufsagenten, darunter J.P. Morgan, UBS und Wells Fargo, bekanntgegeben wird. Die Änderung erhöht die Aktienkapazität um 61.939.730 Aktien und hebt die Gesamtanzahl der unter dem Programm ausgebbaren Aktien auf 161.292.973 Stammaktien an. Nach vorherigen Emissionen sind etwa 75 Millionen Aktien noch verfügbar zum Verkauf.

Die neuen Aktien sind im Formular S-3 des Unternehmens (Datei Nr. 333-289004) registriert. Die Verkäufe erfolgen von Zeit zu Zeit über die Agenten als "At-the-Market-Angebote" gemäß Regel 415(a)(4); die Agenten erhalten übliche Gebühren und Provisionen. Dynex hat zudem (i) den vollständigen Text der Änderung Nr. 7 (Ex. 10.1) und (ii) ein Rechtsgutachten von Mayer Brown LLP zur Gültigkeit der Aktien (Ex. 5.1/23.1) eingereicht.

Auswirkungen für Investoren:

  • Liquiditätssteigerung: Die Erweiterung des ATM-Programms gibt dem Management die Flexibilität, schnell Kapital zu beschaffen, ohne ein traditionelles Folgeangebot.
  • Verwässerungsrisiko: Die Ausgabe von bis zu 75 Millionen zusätzlichen Aktien würde die bestehenden Aktionäre erheblich verwässern, falls vollständig platziert.
  • Keine operativen Kennzahlen: Die Einreichung enthält keine Updates zu Gewinn, Verschuldung oder Buchwert; die Änderung betrifft ausschließlich die Kapitalbeschaffungskapazität.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
White Tiffany B.

(Last) (First) (Middle)
11440 TOMAHAWK CREEK PARKWAY

(Street)
LEAWOOD KS 66211

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
FIRST BUSEY CORP /NV/ [ BUSE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/25/2025 A 77(1) A $0 7,248 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents dividend equivalent rights accrued on Deferred Stock Units in connection with the payment of a cash dividend on First Busey Corporation Stock. Each dividend equivalent right is the economic equivalent of one share of First Busey Corporation Stock.
Remarks:
/s/ Catherine Alqallaf, attorney-in-fact 07/29/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Dynex Capital (DX) announce in its July 29 2025 8-K?

The company increased its at-the-market equity program by 61.9 M shares to a total of 161.3 M common shares.

How many DX shares remain available for issuance after Amendment No. 7?

Approximately 75 million shares can still be issued under the amended ATM agreement.

Why is the amendment considered material to investors?

It gives Dynex a large equity-raising capacity, which can improve liquidity but may dilute existing shareholdings.

Which sales agents are involved in Dynex’s expanded ATM program?

BTIG, Citizens JMP, Janney, JonesTrading, J.P. Morgan, KBW, RBC, UBS and Wells Fargo act as sales agents.

Does the 8-K include any earnings or book-value information?

No. The filing is limited to the capital-raising amendment and related legal exhibits.
First Busey

NASDAQ:BUSE

BUSE Rankings

BUSE Latest News

BUSE Latest SEC Filings

BUSE Stock Data

2.02B
83.73M
6.01%
61.22%
1.59%
Banks - Regional
State Commercial Banks
Link
United States
URBANA